HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomohiko Matsuo Selected Research

Infarction (Infarctions)

1/2022Energy-sparing by 2-methyl-2-thiazoline protects heart from ischaemia/reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomohiko Matsuo Research Topics

Disease

2Hypothermia
01/2022 - 01/2021
2Reperfusion Injury
01/2022 - 01/2021
2Starvation
01/2018 - 04/2007
1Infarction (Infarctions)
01/2022
1Hypoxia (Hypoxemia)
01/2022
1Heart Diseases (Heart Disease)
01/2022
1Brain Ischemia (Cerebral Ischemia)
01/2021
1Tibial Meniscus Injuries
10/2019
1Ganglion Cysts (Ganglion)
08/2012
1Infertility (Sterility)
06/2003

Drug/Important Bio-Agent (IBA)

22-methylthiazolineIBA
01/2022 - 01/2021
2NitrogenIBA
01/2018 - 04/2007
1TroponinIBA
01/2022
1Oxidoreductases (Dehydrogenase)IBA
01/2021
1Pyruvic Acid (Pyruvate)IBA
01/2021
1Therapeutic UsesIBA
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2018
1Transfer RNA (tRNA)IBA
01/2018
1Neuropilin-1IBA
08/2012
1TOR Serine-Threonine KinasesIBA
04/2007
1Phosphotransferases (Kinase)IBA
06/2003

Therapy/Procedure

1Induced Hypothermia
01/2022
1Therapeutics
01/2022
1Anterior Cruciate Ligament Reconstruction
10/2019